Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  MANAGEMENT DISCUSSION
Management Discussion      
Supha Pharmachem Ltd.
BSE Code 539561
ISIN Demat INE549S01036
Book Value 1.03
NSE Code NA
Dividend Yield % 0.00
Market Cap 599.75
P/E 0.00
EPS -0.02
Face Value 1  
Year End: March 2015
 

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

INDUSTRY STRUCTURE AND DEVELOPMENTS AND OTHER RELATED MATTERS

During the financial year 2014-2015, the Company's operations performance has improved significantly. However, financial performance has been adversely affected due to external factors resulting in high cost of sales and weak finished goods prices. Though the Global economy has slowed down, mainly due to lower growth rates in emerging economies such as China and India. This has resulted in weaking of commodity prices which has been adversely affected upon our industry.

OVERVIEW

During the year, your company has earned operating income of Rs.211.90 lacs and a profit before tax of Rs.72.82 Lacs. The management is hopeful to achieve the better performance in the next year. The management of your company accepts the responsibility for the integrity and objectivity of the financial statements.

SWOT ANALSIS

Strength

• Promoters are experienced of more than 27 years in the line of Cycle parts business.

• Competitive.

• Prompt responsiveness to customer and their requirements.

• Increasing customer relationship base resulted in continuous growing industry.

• No worker unrest being a trading company.

Weaknesses

Shortage of demand

More than 90% revenue from single segment - trading and manufacturing of Cycle parts Low supply and automation Level: Highly dependent on other steel industries.

Opportunities

• Growing domestic deman d with the improvements in sentiments in general.

Threats

Increase in competition. Uncertain in cycle market.

INTERNAL CONTROL SYSTEMS

The company has proper and adequate internal control systems commensurate with its size and nature of operations to provide reasonable assurance that all the assets are safeguarded, transaction are recorded and reported properly and all applicable statutes and corporate policies are duly complied with.

MATERIAL DEVELOPMENTS IN HUMAN RESOURCES

There are no significant developments to report on the Human Resource Front. The company enjoys a harmonious relationship with its employees.

SEGMENT WISE/PRODUCT WISE PERFORMANCE

The company has been trading in iron and steel and its allied products and continues to improve its position in the same area.

CAUTIONARY STATEMENTS

Statements in the Management Discussion and Analysis Report describing the Company's activities, projections about the future, estimates, assumptions with regard to economic conditions and Government policies etc. have been made in good faith and may be "forward looking statements" within the meaning of applicable securities laws and regulations. Many unforeseen factors may come into play and affect the actual results which might differ from those either exbrssed or implied. Market data was based on information gathered from various published and unpublished sources and their accuracy, reliability and completeness cannot be assured.

By the order of Board of Directors

For Roxy Exports Limited

sd/- Amit Mittal

DIN:01691317 (Whole Time Director)

sd/- Subhash Chander Mittal

DIN: 02739014

(Managing Director)

Place: Ludhiana

Dated: 1st September, 2015

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.